Takuo Hashimoto
About Takuo Hashimoto
Takuo Hashimoto is a Product Manager for Endoscopy at Boston Scientific Japan K.K., with a background in sales and marketing and a Bachelor of Arts in English Language and Literature from 関西外国語大学.
Current Role at Boston Scientific Japan K.K.
Takuo Hashimoto currently holds the position of Product Manager, Endoscopy at Boston Scientific Japan K.K. He has been in this role since 2019. Based in the 23 wards of Tokyo, he is responsible for managing endoscopy products, ensuring their alignment with market needs, and driving product strategy.
Previous Experience at Boston Scientific Japan K.K.
Before his current role, Takuo Hashimoto served as an Associate Product Manager in Endoscopy from 2017 to 2019 at Boston Scientific Japan K.K. During these two years, he worked extensively on product strategies and management, contributing to the company's growth in endoscopy solutions.
Professional Experience at Arthrex Japan G.K.
From 2014 to 2017, Takuo Hashimoto worked as a Product Marketing Manager at Arthrex Japan G.K. Located in Tokyo, his responsibilities included overseeing product marketing initiatives and managing the product life cycle, ensuring that products met market demands and aligned with corporate objectives.
Early Career at Mokuda Dental Co., Ltd.
Takuo Hashimoto began his career in sales and marketing at Mokuda Dental Co., Ltd. in Kobe, Hyogo. From 2011 to 2014, he focused on driving sales initiatives and marketing strategies for dental products, establishing a strong foundation in healthcare product management.
Educational Background
Takuo Hashimoto holds a Bachelor of Arts (B.A.) in English Language and Literature from Kansai Gaidai University, where he studied from 2007 to 2011. His education provided him with a strong foundation in communication, which has been instrumental in his professional roles.
Product Line Management
During his tenure at Boston Scientific Japan K.K., Takuo Hashimoto managed the product line for endoluminal surgery products during the transition period of 2020-2021. Additionally, he oversaw the biliary/duodenum metal stents product line from 2021 to 2022, ensuring their alignment with clinical needs and market trends.